bio113 Flashcards
(140 cards)
Pleiotropy
Where a single gene has multiple effects on the phenotype it is said to be pleiotropic
Polygenic Inheritance
Where a single trait is determined by multiple genes
Epistasis
When one gene masks or modifies the expression of another gene it is said to be epistatic to that gene
3 ways to identify chromosome
length
banding pattern
placement of centromere
acrocenctric
centromere very close to the end
polyploidy
extra whole sets of chromosomes
aneuploidy
some additional or missing chromosomes
trisomy and an example
trisomy is one extra chromosome and an example is downsyndrome
Cytogenetics
Study of chromosome structure and function.
Karyotyping Process
Collect blood (10-20 ml). Stimulate mitosis using phytohaemagglutinin. Incubate cells (2-3 days). Halt mitosis in metaphase using colcemid. Lyse cells with hypotonic solution. Fix, stain (Giemsa), and arrange chromosomes by size.
Chromosome Classification
Metacentric: Centromere in center. Sub-metacentric: Centromere slightly off-center. Acrocentric: Centromere very close to one end. Chromosomes identified by length, banding pattern, centromere placement.
Polyploidy
Additional whole chromosome sets. Examples: Triploid (3n), Tetraploid (4n). Common in plants (e.g., cultivated banana, 3n=33); rare in animals.
Aneuploidy
Additional or missing chromosomes. Types: Monosomy: Missing one chromosome. Trisomy: Extra chromosome. Example: Trisomy 18 (47, XX, +18).
Non-disjunction
Failure of chromosomes or chromatids to separate during meiosis. Occurs: Meiosis I: Homologous chromosomes. Meiosis II: Sister chromatids. Common, leads to ~50% human conceptions being aneuploid.
Down’s Syndrome (Trisomy 21)
Karyotype: 47, XX/XY, +21. Characteristics: Distinct facial features, short stature, learning disabilities. Heart defects, increased risk of leukemia and Alzheimer’s. Risk factor: Maternal age.
Screening for Down’s Syndrome
Methods: Blood tests (specific protein markers). Ultrasound (nuchal pad thickness). Amniocentesis and karyotyping.
Turner’s Syndrome (XO)
Karyotype: 45, XO. Characteristics: Phenotypically female, sterile. Lack mature sexual organs; secondary characteristics develop with estrogen replacement therapy. Incidence: 1 in 2500 live female births.
Klinefelter’s Syndrome (XXY)
Karyotype: 47, XXY. Characteristics: Essentially male phenotype, sterile. Some female traits, tall stature. Treated with testosterone therapy. Incidence: 1:500-1000 live male births.
Sex Determination
Determined by presence or absence of Y chromosome: Turner’s Syndrome (XO): essentially female. Klinefelter’s Syndrome (XXY or XXXY): essentially male.
Chromosome Structural Changes
Types: Deletions, translocations. Identified precisely by chromosome ‘address’ (banding pattern).
Cri-du-chat Syndrome (Deletion)
Deletion: Short arm of chromosome 5 (5p-). Characteristics: Cat-like cry (larynx/glottis abnormality). Wide face, saddle nose, intellectual/physical disabilities. Incidence: ~1 in 50,000 live births.
Prader-Willi Syndrome
Deletion: Long arm chromosome 15 (15q1.12), paternal chromosome. Characteristics: Poor infant feeding, obesity, diabetes, poor sexual development in males. Due to genomic imprinting (maternal or paternal gene silencing).
Chronic Myelocytic Leukaemia (CML) (Translocation)
Cause: Reciprocal translocation between chromosomes 22 and 9, creating the Philadelphia chromosome. Result: BCR-ABL fusion gene (oncogene) stimulates excessive white blood cell production. Characteristics: High white blood cell count. Common in middle-aged/elderly individuals. Accounts for 15-20% leukemia cases.
Mendel
Established principles of heredity (dominant/recessive traits).